Related Experiment Video
Updated: Aug 17, 2025
06:32
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
5.2K
Prostate adenocarcinoma presenting as diffuse osteolytic metastasis
Mohanad Faisal1, Abdulrahman F Al-Mashdali1, Noor Jasim1
1Internal Medicine Department Hamad Medical Corporation Doha Qatar.
Clinical Case Reports
|December 16, 2022
Summary
Prostate cancer commonly spreads to bone, but usually causes osteoblastic lesions. This report details a rare case of diffuse osteolytic lesions from metastatic prostate cancer identified via MRI.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Prostate cancer is a leading cause of cancer metastasis.
- Bone metastasis from prostate cancer is typically osteoblastic.
- Osteolytic lesions are an uncommon presentation of prostate cancer bone metastasis.
Observation:
- A patient presented with diffuse osteolytic bone lesions.
- Magnetic Resonance Imaging (MRI) was utilized for diagnostic imaging.
Findings:
- The patient was diagnosed with metastatic prostate cancer.
- The diffuse osteolytic nature of the bone lesions was confirmed.
Implications:
- Highlights the importance of considering prostate cancer in differential diagnoses for osteolytic bone lesions.
- Suggests MRI can be valuable in identifying unusual patterns of prostate cancer bone metastasis.
- Underscores the need for further research into the mechanisms of osteolytic prostate cancer metastasis.
